United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Technology Industry News Viasat shocks Wall Street: Stock erupts 30% after surprise Q1 profit and satellite wins Viasat shares jumped 30% after beating Q1 FY26 estimates and showcasing major defense and satellite momentum. Find out why investors are piling in. byPallavi MadhirajuAugust 6, 2025